RYPLAZIM PLASMINOGEN Trademark

Trademark Overview

On Friday, November 25, 2016, a trademark application was filed for RYPLAZIM PLASMINOGEN with the United States Patent and Trademark Office. The USPTO has given the RYPLAZIM PLASMINOGEN trademark a serial number of 87247936. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2019. This trademark is owned by ProMetic BioTherapeutics, Inc.. The RYPLAZIM PLASMINOGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies
ryplazim plasminogen

General Information

Serial Number87247936
Word MarkRYPLAZIM PLASMINOGEN
Filing DateFriday, November 25, 2016
Status700 - REGISTERED
Status DateTuesday, December 10, 2019
Registration Number5929629
Registration DateTuesday, December 10, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements

Description of MarkThe mark consists of the wording "RYPLAZIM PLASMINOGEN", to the right of a group of four shapes consisting of three pairs of curved lines having tapered ends, and an oval partly enclosed within an outer band.
Goods and ServicesPharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PLASMINOGEN"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKEDRION BIOPHARMA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFORT LEE, NJ 07024
Party NameProMetic BioTherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameProMetic BioTherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameProMetic BioTherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Wednesday, December 6, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 29, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 16, 2019NOTICE OF ALLOWANCE CANCELLED
Friday, August 9, 2019PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, August 9, 2019ASSIGNED TO PETITION STAFF
Wednesday, July 10, 2019TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019SOU EXTENSION 4 GRANTED
Monday, June 3, 2019SOU EXTENSION 4 FILED
Monday, June 3, 2019SOU TEAS EXTENSION RECEIVED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2018SOU EXTENSION 3 GRANTED
Wednesday, December 12, 2018SOU EXTENSION 3 FILED
Wednesday, December 12, 2018SOU TEAS EXTENSION RECEIVED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 9, 2018SOU EXTENSION 2 GRANTED
Wednesday, May 9, 2018SOU EXTENSION 2 FILED
Wednesday, May 9, 2018SOU TEAS EXTENSION RECEIVED
Friday, October 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 11, 2017SOU EXTENSION 1 GRANTED
Wednesday, October 11, 2017SOU EXTENSION 1 FILED
Wednesday, October 11, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 3, 2017EXAMINER'S AMENDMENT ENTERED
Friday, March 3, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 3, 2017EXAMINERS AMENDMENT E-MAILED
Friday, March 3, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 1, 2017ASSIGNED TO EXAMINER
Friday, December 2, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 29, 2016NEW APPLICATION ENTERED

Related Keywords

plasminogen ryplazim deficiencies associated conditions preparations treatment pharmaceutical